GlassScriptPhysician profile
Robyn Ostapow
NPI 1104819341
$3,117.63
in general payments reported to CMS, 2019-2025
31 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $928 · 2022: $704 · 2023: $476 · 2024: $624 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $459.96 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $359.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $313.25 | 2022-2025 | |
| Nestle Healthcare Nutrition INC. | $194.09 | 2021 | |
| Pfizer INC. | $158.77 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $150.17 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $150.15 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Teva Pharmaceuticals USA, INC. | $143.56 | 2021-2022 | |
| Lilly USA, LLC | $127.56 | 2023-2025 | Jardiance, Zepbound |
| Amgen INC. | $116.88 | 2021-2024 | Prolia, Evenity |
| Exact Sciences Corporation | $115.45 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $107.44 | 2021-2023 | |
| Viiv Healthcare Company | $98.76 | 2021-2024 | Apretude, Dovato |
| Insmed, INC. | $89.00 | 2022 | |
| Xeris Pharmaceuticals, INC. | $54.43 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $53.94 | 2025 | Camzyos |
| Hologic Sales and Service, LLC | $50.34 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Biohaven Pharmaceuticals, INC. | $46.72 | 2021 | |
| Amarin Pharma, INC. | $42.78 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $38.55 | 2023-2024 | Inpefa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.34 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.39 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.91 | 2022 | |
| Eisai INC. | $27.35 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $23.32 | 2023 | |
| Abbott Laboratories | $21.45 | 2024 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $18.60 | 2024 | |
| Lucid Diagnostics INC. | $15.88 | 2025 | |
| Daiichi Sankyo INC. | $15.26 | 2023 | Injectafer |
| Sanofi Pasteur INC. | $12.75 | 2021 | |
| Bardy Diagnostics, INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Ostapow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.